Search Results - "Gurnani, Payal"

Refine Results
  1. 1

    Outcomes of Extubated COVID and Non-COVID Patients Receiving Awake Venovenous Extracorporeal Membrane Oxygenation by Gurnani, Payal K., Michalak, Lauren A., Tabachnick, Deborah, Kotwas, Michael, Tatooles, Antone J.

    Published in ASAIO journal (1992) (01-04-2022)
    “…Cessation of continuous analgesia and sedation in patients with acute respiratory distress syndrome (ARDS) receiving venovenous (VV) extracorporeal membrane…”
    Get full text
    Journal Article
  2. 2

    Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department by Hammond, Drayton A., Gurnani, Payal K., Flannery, Alexander H., Smetana, Keaton S., Westrick, Jennifer C., Lat, Ishaq, Rech, Megan A.

    Published in Pharmacotherapy (01-03-2019)
    “…A framework for evaluating pharmacists’ impact on cost avoidance in the intensive care unit (ICU) and emergency department (ED) has not been established. This…”
    Get full text
    Journal Article
  3. 3

    In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients by Li, Jie, Augustynovich, Ashley E, Gurnani, Payal K, Fink, James B

    Published in Respiratory research (21-08-2021)
    “…Inhaled epoprostenol (iEPO) has been shown to reduce pulmonary artery pressure and improve oxygenation. iEPO is mainly delivered via a syringe pump with feed…”
    Get full text
    Journal Article
  4. 4

    Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation by Sullivan, Jaclyn, Bak, Erica, Sullivan, Mary Jane, Gurnani, Payal K.

    Published in Perfusion (01-07-2020)
    “…There are currently no scoring tools validated for use in predicting heparin-induced thrombocytopenia in patients receiving extracorporeal membrane…”
    Get full text
    Journal Article
  5. 5

    Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy by Khan, Attiya A., Gurnani, Payal K., Peksa, Gary D., Whittier, William L., DeMott, Joshua M.

    Published in The Annals of pharmacotherapy (01-03-2021)
    “…Background Historically, intravenous (IV) bisphosphonates with calcitonin are the treatment of choice for hypercalcemia of malignancy. However, evidence is…”
    Get full text
    Journal Article
  6. 6

    PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study by Rech, Megan A, Gurnani, Payal K, Peppard, William J, Smetana, Keaton S, Van Berkel, Megan A, Hammond, Drayton A, Flannery, Alexander H

    Published in Critical care explorations (10-12-2021)
    “…To comprehensively classify interventions performed by ICU clinical pharmacists and quantify cost avoidance generated through their accepted interventions. A…”
    Get full text
    Journal Article
  7. 7

    Under the Microscope: A Look Into the Role of Critical Care Pharmacists During the COVID-19 Pandemic by Gurnani, Payal K., Peksa, Gary D., Panos, Nicholas G., DeMott, Joshua M.

    Published in Journal of Pharmacy Practice (01-12-2022)
    “…Among disciplines, the COVID-19 pandemic has reinforced the importance of critical care pharmacists in assuming responsibility for managing medication therapy…”
    Get full text
    Book Review Journal Article
  8. 8

    The Clinical Impact of Flow Titration on Epoprostenol Delivery via High Flow Nasal Cannula for ICU Patients with Pulmonary Hypertension or Right Ventricular Dysfunction: A Retrospective Cohort Comparison Study by Li, Jie, Gurnani, Payal K, Roberts, Keith M, Fink, James B, Vines, David

    Published in Journal of clinical medicine (07-02-2020)
    “…(1) Background: inhaled epoprostenol (iEPO) delivered via high-flow nasal cannula (HFNC) has been reported to be effective for pulmonary hypertension and right…”
    Get full text
    Journal Article
  9. 9

    Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation by Servais, Ryan, Ammar, Mahmoud A, Gurnani, Payal K

    Published in BMJ case reports (01-06-2019)
    “…Blastomycosis-associated acute respiratory distress syndrome (ARDS) has a rare incidence. We report the case of a 29-year-old man with blastomycosis-associated…”
    Get full text
    Journal Article
  10. 10

    A Case of Linezolid Induced Toxicity by Tobias, Philip E., Varughese, Christy A., Hanson, Amy P., Gurnani, Payal K.

    Published in Journal of pharmacy practice (01-04-2020)
    “…Adverse effects of linezolid are typically limited to diarrhea, nausea, and headache when shorter durations are used; however, as extended durations of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation by Gurnani, Payal K., Bohlmann, Allison, March, Robert J.

    Published in Perfusion (01-11-2018)
    “…Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used as a bridge to cardiac recovery in patients following a major cardiac…”
    Get full text
    Journal Article
  15. 15
  16. 16

    PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study by Rech, Megan A, Adams, William, Smetana, Keaton S, Gurnani, Payal K, Van Berkel Patel, Megan A, Peppard, William J, Hammond, Drayton A, Flannery, Alexander H

    Published in Critical care explorations (26-04-2021)
    “…To comprehensively classify interventions performed by emergency medicine clinical pharmacists and quantify cost avoidance generated through their accepted…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20